Vimarsana
Biggest News Aggregation in the World

Page 12 - Beta Blocker News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Beta Blocker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Beta Blocker Today - Breaking & Trending Today

Global Atherosclerosis Drugs Market to Reach $27.71 Billion - Vimarsana News

Global Atherosclerosis Drugs Market to Reach $27.71 Billion

Dublin, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The

Guideline-Directed Therapy in oHCM - Vimarsana News

Guideline-Directed Therapy in oHCM

Andrew Wang, MD, comments on the treatment algorithm for symptomatic oHCM, highlighting treatment guidelines, and James Januzzi, MD, reviews treatment selection for oHCM through the lens of the patient’s quality of life.

Beta Blockers For Anxiety: 2023 Uses, Benefits & Side Effects - Vimarsana News

Beta Blockers For Anxiety: 2023 Uses, Benefits & Side Effects

Discover how beta blockers for anxiety can bring peace to your life. Explore the effectiveness of these treatment options.

Foundations of Quadruple Therapy in Heart Failure - Vimarsana News

Foundations of Quadruple Therapy in Heart Failure

Experts in cardiology highlight the four pillars of guideline directed therapies in heart failure.

Cytokinetics Announces Start of MAPLE-HCM, a Phase 3 Clinical Trial of Aficamten Compared to Metoprolol in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy - Vimarsana News

Cytokinetics Announces Start of MAPLE-HCM, a Phase 3 Clinical Trial of Aficamten Compared to Metoprolol in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy

First Phase 3 Trial Evaluating Monotherapy with a Cardiac Myosin Inhibitor Compared to Monotherapy with a Beta Blocker in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy SOUTH SAN... | June 20, 2023